audreyford
by on August 16, 2023
121 views

The growing pipeline of biologics and challenges associated with their manufacturing have prompted stakeholders in the biopharmaceutical industry to adopt cell free expression systems for effective synthesis of biotherapeutics 

 

Roots Analysis is pleased to announce the publication of its recent study, titled, Cell Free System: Cell Free Expression Kits and Service Providers, 2023-2035.

 

The cell free market report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry, across different regions. Amongst other elements, the research report includes:

  • An executive summary of insights captured during our research. 
  • A general overview of cell free systems, the different types of such systems and their composition. It provides a brief outline of the cell free expression process, highlighting several challenges and advantages associated with this technique
  • A detailed assessment of the current market landscape of cell free expression service providers.
  • A detailed assessment of the current market landscape of cell free expression kits, based on several relevant parameters.
  • A comprehensive company competitiveness analysis of cell free expression service providers.
  • A product competitiveness analysis of cell free expression kits based on various relevant parameters.
  • Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) offering cell free expression services.
  • Elaborate profiles of prominent players engaged in development of cell free expression kits (shortlisted based on a proprietary criterion).
  • A detailed analysis of recent partnerships inked between stakeholders engaged in this industry, from 2018.
  • An analysis of the funding and investments made in the cell free expression market, since 2018.
  • An in-depth analysis of various patents that have been filed / granted related to cell free systems since 2015.
  • A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

 

  • Type of Cell Free System
    • Crude Cell Lysate-based Systems
    • Reconstituted Systems

 

  • Type of Host Organism
    • Microbial Cell Free Expression System                                
    • Mammalian Cell Free Expression Systems                          
    • Plant-based Cell Free Expression Systems                         
    • Other Cell Free Expression Systems

 

  • Type of Expression Method
    • Coupled Transcription and Translation Method
    • Translation Method

 

  • End-User
    • Pharmaceutical and Biotechnology Companies                               
    • Academic and Research Institutes
    • Other End-Users

 

  • Key Geographical Regions 
    • North America
    • Europe
    • Asia Pacific
    • Rest of the World

 

Key companies covered in the report

  • BioLinker
  • biotechrabbit
  • CellFree Sciences
  • Creative Biolabs
  • CUSABIO
  • Daicel Arbor Biosciences
  • LenioBio
  • Promega
  • Thermo Fisher Scientific
  • Touchlight

 

For additional details, please visit https://www.rootsanalysis.com/reports/cell-free-expression-market.html

Learn from experts:  do you know about these emerging industry trends?

Digital Therapies: The “Digital Pills” of current generation

Medical Device Coatings and Modification Technologies

 

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

 

Learn more about Roots Analysis consulting services: 

Roots Analysis Consulting - the preferred research partner for global firms

 

Contact:

Ben Johnson

+1 (415) 800 3415

 

 

 

Posted in: Health
Be the first person to like this.